Prothrombotic factors and the risk of acute onset non-cardioembolic stroke in young Asian Indians

被引:18
|
作者
Biswas, Arijit [1 ]
Ranjan, Ravi [1 ]
Meena, Arvind [1 ]
Akhter, Suhail [1 ]
Sharma, Vinita [1 ]
Yadav, Birendra Kumar [1 ]
Behari, Madhuri [1 ]
Saxena, Renu [1 ]
机构
[1] All India Inst Med Sci, Dept Hematol, New Delhi 110029, India
关键词
Factor V Leiden mutation; Factor V HR2 Haplotype; Coagulation Inhibitors; Factor VIII levels; Acute phase; Asian-Indians; ACTIVATED PROTEIN-C; FACTOR-V-LEIDEN; ISCHEMIC-STROKE; VENOUS THROMBOEMBOLISM; FACTOR V-R506Q; RESISTANCE; MUTATION; MARKERS; INACTIVATION; THROMBOPHILIA;
D O I
10.1016/j.thromres.2009.02.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Several prothrombotic factors - both hereditary and acquired - are known to cause stroke. Commonly investigated causes are activated protein C resistance, factor V Leiden mutation, factor VIII levels, prothrombin 20210 G-to-A mutation, coagulation inhibitors such as proteins C and S, and anti phospholipid antibodies such as beta(2)-glycoprotein. Objective: The literature on the prevalence of hematological defects pertaining to these variables in the Asian Indian stroke population is limited to a few isolated reports. In the current study we investigate the above-mentioned variables in 120 stroke patients (non-cardioembolic acute-onset stroke) and compare their status with the hematological profile of an equal number of healthy age- and sex-matched controls. Material and Methods: Plasma and blood leukocytes were collected from all patients and controls for performing hematological assays and molecular tests respectively. The mutations were detected using standard polymerase chain reaction/restriction fragment length polymorphism (PCR/RFLP) procedures. Statistical analysis was done using SPSS version 12.0. Results: Factor V Leiden (prevalence 8.3% in patients) and activated protein C resistance (prevalence 19.6% in patients) both showed a high degree of association (P<0.01) with the disease condition. However, contrary to common expectations, factor V Leiden was observed much less frequently in patients showing activated protein C resistance (10 out of 23; 43.4%) than is commonly observed in the Caucasian population (almost 90%). Post-acute-phase factor VIII levels were also found to be significantly associated with stroke: 125.6 + 21.1% number of profitable positions (NPP) for controls and 136.2 + 28.8% NPP for patients (P = 0.001). Conclusion: factor V mutations, such as factor V Leiden, may be important risk factors for stroke in an Asian Indian population. Activated protein C resistance has a stronger association with stroke than factor V Leiden and may be caused by other factors such as elevated factor VIII levels in the Asian Indian population apart from factor V Leiden itself. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:397 / 402
页数:6
相关论文
共 50 条
  • [41] Prevalence of asymptomatic peripheral artery disease in patients with non-cardioembolic ischemic stroke
    Alvarez-Sabin, J.
    Gil-Nunez, A.
    Quintana, M.
    Barbera, G.
    NEUROLOGIA, 2009, 24 (06): : 366 - 372
  • [42] Disease Burden Following Non-Cardioembolic Minor Ischemic Stroke or High-Risk TIA: A GWTG-Stroke Study
    Kaufman, Brystana G.
    Shah, Shreyansh
    Hellkamp, Anne S.
    Lytle, Barbara L.
    Fonarow, Gregg C.
    Schwamm, Lee H.
    Lesen, Eva
    Hedberg, Jonatan
    Tank, Amarjeet
    Fita, Edmond
    Bhalla, Narinder
    Atreja, Nipun
    Bettger, Janet Prvu
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2020, 29 (12):
  • [43] Biomarker and genomic analyses reveal molecular signatures of non-cardioembolic ischemic stroke
    Ding, Lingling
    Liu, Yu
    Meng, Xia
    Jiang, Yong
    Lin, Jinxi
    Cheng, Si
    Xu, Zhe
    Zhao, Xingquan
    Li, Hao
    Wang, Yongjun
    Li, Zixiao
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 8 (01)
  • [44] Prevalence of the metabolic syndrome in patients with transient ischemic attack or non-cardioembolic stroke
    Gil-Nunez, A.
    Alvarez-Sabin, J.
    Quintana, M.
    Barbera, G.
    NEUROLOGIA, 2009, 24 (07): : 446 - 453
  • [45] Effects of policosanol in the functional recovery of non-cardioembolic ischemic stroke hypertensive patients
    Sanchez-Lopez, Javier
    Fernandez-Travieso, Julio C.
    Illnait-Ferrer, Jose
    Fernandez-Dorta, Lilia
    Mendoza-Castano, Sarahi
    Mas-Ferreiro, Rosa
    Mesa-Angarica, Meilis
    Reyes-Suarez, Pablo
    REVISTA DE NEUROLOGIA, 2018, 67 (09) : 331 - 338
  • [46] Biomarker and genomic analyses reveal molecular signatures of non-cardioembolic ischemic stroke
    Lingling Ding
    Yu Liu
    Xia Meng
    Yong Jiang
    Jinxi Lin
    Si Cheng
    Zhe Xu
    Xingquan Zhao
    Hao Li
    Yongjun Wang
    Zixiao Li
    Signal Transduction and Targeted Therapy, 8
  • [47] Administration of Cilostazol Clarifies the Burden Atrial Fibrillation in Non-Cardioembolic Stroke.
    Aoki, Junya
    Kimura, Kazumi
    Abe, Koji
    Uno, Masaaki
    Okada, Yasushi
    Urabe, Takao
    Fujimoto, Shigeru
    Matsuoka, Hideki
    Yamagata, Sen
    Yamagami, Hiroshi
    Yamamoto, Yasumasa
    Yonehara, Toshiro
    Inoue, Takeshi
    STROKE, 2019, 50
  • [48] Reasons and risk factors of cardioembolic stroke
    Novikova, L.
    Akopian, A.
    Sharapova, K.
    Latypova, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 797 - 797
  • [49] Heart rate variability and delirium in acute non-cardioembolic stroke: a prospective, cross-sectional, cohort study
    Rollo, Eleonora
    Marotta, Jessica
    Callea, Antonio
    Brunetti, Valerio
    Vollono, Catello
    Scala, Irene
    Imperatori, Claudio
    Frisullo, Giovanni
    Broccolini, Aldobrando
    Della Marca, Giacomo
    NEUROLOGICAL SCIENCES, 2022, 43 (04) : 2423 - 2431
  • [50] A Nomogram for Predicting the Recurrence of Acute Non-Cardioembolic Ischemic Stroke: A Retrospective Hospital-Based Cohort Analysis
    Shao, Kangmei
    Zhang, Fan
    Li, Yongnan
    Cai, Hongbin
    Maswikiti, Ewetse Paul
    Li, Mingming
    Shen, Xueyang
    Wang, Longde
    Ge, Zhaoming
    BRAIN SCIENCES, 2023, 13 (07)